JP2014533495A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014533495A5 JP2014533495A5 JP2014541599A JP2014541599A JP2014533495A5 JP 2014533495 A5 JP2014533495 A5 JP 2014533495A5 JP 2014541599 A JP2014541599 A JP 2014541599A JP 2014541599 A JP2014541599 A JP 2014541599A JP 2014533495 A5 JP2014533495 A5 JP 2014533495A5
- Authority
- JP
- Japan
- Prior art keywords
- factor viii
- agent
- cell
- viii polypeptide
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11189861.5 | 2011-11-21 | ||
| EP11189861 | 2011-11-21 | ||
| US201161563188P | 2011-11-23 | 2011-11-23 | |
| US61/563,188 | 2011-11-23 | ||
| PCT/EP2012/071701 WO2013075926A1 (en) | 2011-11-21 | 2012-11-02 | Method for production of factor viii |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014533495A JP2014533495A (ja) | 2014-12-15 |
| JP2014533495A5 true JP2014533495A5 (https=) | 2015-12-24 |
Family
ID=48469150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014541599A Withdrawn JP2014533495A (ja) | 2011-11-21 | 2012-11-02 | 第ｖｉｉｉ因子の生産のための方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20140308707A1 (https=) |
| EP (1) | EP2782929A1 (https=) |
| JP (1) | JP2014533495A (https=) |
| CN (1) | CN103946235A (https=) |
| WO (1) | WO2013075926A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017118764A1 (en) * | 2016-01-07 | 2017-07-13 | Thomas Brocker | Novel approaches for the in vivo and in vitro visualization of dying cells |
| CN106167527A (zh) * | 2016-06-13 | 2016-11-30 | 长沙郝怡雅医药科技有限公司 | 一种融合蛋白 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060099685A1 (en) * | 1999-04-15 | 2006-05-11 | Yallop Christopher A | Recombinant expression of factor VIII in human cells |
| AU2003237870A1 (en) * | 2002-06-07 | 2003-12-22 | The Brigham & Women's Hospital, Inc. | Method and composition for inhibing or slowing blood coagulation |
| WO2007124106A2 (en) * | 2006-04-21 | 2007-11-01 | Bayer Healthcare Llc | Application of antl-apoptotic genes in mammalian cells for perfusion culture. |
| EP1988101A1 (en) * | 2007-05-04 | 2008-11-05 | Novo Nordisk A/S | Improvement of factor VIII polypeptide titers in cell cultures |
-
2012
- 2012-11-02 WO PCT/EP2012/071701 patent/WO2013075926A1/en not_active Ceased
- 2012-11-02 US US14/358,886 patent/US20140308707A1/en not_active Abandoned
- 2012-11-02 CN CN201280057127.6A patent/CN103946235A/zh not_active Withdrawn
- 2012-11-02 EP EP12779084.8A patent/EP2782929A1/en not_active Withdrawn
- 2012-11-02 JP JP2014541599A patent/JP2014533495A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201991976A1 (ru) | Метаболически оптимизированная клеточная культура | |
| AR127516A2 (es) | VARIANTES DE Fc Y MÉTODOS PARA SU PRODUCCIÓN | |
| AR080942A1 (es) | Produccion de proteinas heteromultimericas | |
| NZ591292A (en) | Improved cell composition and methods of making the same | |
| UY35020A (es) | Desempeño de ubicación de fad2 y su correspondiente sitio de incidencia específica de las proteínas de unión capaces de inducir rupturas ya seleccionadas. | |
| CL2013002361A1 (es) | Metodo para medir actividad de células natural killer (nk); kit para medir dicha actividad; proteína de fusión; composicion para activar células nk; polipéptido, oligonucleótido, vector y célula hospedera que comprenden la proteína; | |
| MX386422B (es) | Moléculas efectoras químericas etiquetadas y receptores de las mismas. | |
| Teixeira et al. | Epitope‐imprinted nanoparticles as transforming growth factor‐β3 sequestering ligands to modulate stem cell fate | |
| BR112015014751A2 (pt) | anticorpos anti-tau humanos | |
| WO2012045082A3 (en) | Engineered nucleic acids and methods of use thereof | |
| AR088513A1 (es) | Inmunoenlazantes dirigidos contra esclerostina | |
| EA201170635A1 (ru) | Композиции, способы получения и применение каркаса на основе домена фибронектина типа iii | |
| HK1216894A1 (zh) | 多價結合蛋白組合物 | |
| EP4296673A3 (en) | Peptides and methods for the detection of lyme disease antibodies | |
| JP2015525572A5 (https=) | ||
| BR122021020829B8 (pt) | Proteína de ligação ao fator h de ocorrência não natural (fhbp), composição, e célula hospedeira de neisseria meningitidis geneticamente modificada | |
| EA201590488A1 (ru) | Способы модификации клеток-хозяев | |
| WO2012018639A3 (en) | Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures | |
| DOP2014000298A (es) | Células para producir iduronato-2-sulfatasa recombinante | |
| WO2006116181A3 (en) | Regulatory t cell mediator proteins and uses thereof | |
| JP2016500260A5 (https=) | ||
| EP4306544A3 (en) | Production of heteromultimeric proteins using mammalian cells | |
| MX357655B (es) | Mediador soluble. | |
| MX2022008298A (es) | Anticuerpo para sesgar proporciones de sexos y metodos de uso del mismo. | |
| WO2015120542A8 (en) | Hybrid proteins and uses thereof |